Vital Images: Coolcat's Super Seven
07/04/2003 12:00 am EST
“Volume has slackened off as market participants ponder whether this is just the pause that refreshes or the start of a bigger retrenchment,” notes Kevin Kennedy, editor of The Coolcat Report, “It's a good time to exercise more caution. I'd frankly be more inclined to do some buying if a decent correction were to unfold in the next couple weeks.” According to the Hulbert Financial Digest, Coolcat’s portfolios have risen at an average annual rate of over 36%. Here’s Kennedy’s latest buy.
“Our latest ‘Super Seven Stock’ is Vital Images (VTAL NASDAQ), a play in computer software for the medical industry. In order to qualify as a Super Seven Stock, the issue must meet all of the following seven criteria: 1) Relative strength of 97 or higher or high-low ratio of four to one or better; 2) A price less than 20 or more than 50; 3) a float of ten million shares or less; 4) a new listing on one of my screens since the last buy signal; 5) a new high in the previous two weeks; 6) volume equal to at least three times its previous volume and up in price day in past two weeks; and 7) a breakout out of a base of four weeks or longer in the past two weeks.
“Vital Images provides 3-D imaging software
for use in disease screening applications, clinical diagnosis, and therapy
planning. The company's technology utilizes high-speed volume visualization and
analysis, as well as network communications based on DICOM and Internet
protocols. Vital Images cost effectively brings 3D visualization and analysis into
the day-to-day practice of medicine. The stock recently set a high of 20.17–up from a low of